RecruitingPhase 3NCT06560255

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma (FREYA)

Sponsor

Professor Klaus Bønnelykke

Enrollment

2,000 participants

Start Date

Dec 20, 2024

Study Type

INTERVENTIONAL

Conditions

Asthma Fractures, Bone Allergy Eczema Respiratory Tract Infections Gastrointestinal Infection Croup Wheezing Development, Child Cognition Disorders in Children Psychiatric Diagnosis

Summary

The overall aim of the study is to develop a nutritional preventive fish oil supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that both supplementations in higher doses than recommended could reduce the risk of disease development.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This trial studies whether taking fish oil during pregnancy can help prevent asthma in young children, focusing on mothers who have low omega-3 fatty acid levels. **You may be eligible if...** - You are a pregnant woman in Denmark, before week 26 of pregnancy - Your blood levels of EPA+DHA (omega-3 fats) are below 4.7% - You are not already planning to take fish oil supplements **You may NOT be eligible if...** - You have endocrine, heart, kidney, or autoimmune disorders - You take blood-thinning medications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTn-3 fatty acid

Oral intake of 4 capsules per day from week 22-26 in pregnancy to 1 week after delivery

OTHERRape seed oil

Oral intake of 4 capsules per day from week 22-26 in pregnancy to 1 week after delivery

Locations(1)

Copenhagen University Hospital of Copenhagen

Gentofte Municipality, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06560255

Related Trials

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

NCT06307665135 locations

Personalized Environment and Genes Study

NCT003412371 location

ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia

NCT073996659 locations

PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults

NCT069811693 locations

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

NCT06023589143 locations